Skip to main content
MANNKIND CORP logo

MANNKIND CORP — Investor Relations & Filings

Ticker · MNKD ISIN · US56400P7069 LEI · 213800GFBCNY1ZFST722 US Manufacturing
Filings indexed 1,205 across all filing types
Latest filing 2022-08-01 Director's Dealing
Country US United States of America
Listing US MNKD

About MANNKIND CORP

https://mannkindcorp.com/

MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of therapeutic products and devices. The company specializes in inhaled therapies for patients with cardiometabolic and orphan lung diseases. Its portfolio includes Afrezza®, an inhaled insulin for diabetes, and Tyvaso DPI®, a dry powder inhaler for pulmonary hypertension developed in collaboration with United Therapeutics. Through its acquisition of scPharmaceuticals, MannKind also markets FUROSCIX®, a subcutaneous treatment for edema in adults with chronic heart failure. The company's pipeline is focused on expanding indications for its existing products, including a pediatric application for Afrezza.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2022-08-01 English
FORM 4 SUBMISSION
Director's Dealing
2022-08-01 English
FORM 4 SUBMISSION
Director's Dealing
2022-08-01 English
FORM 4 SUBMISSION
Director's Dealing
2022-08-01 English
FORM 4/A SUBMISSION
Director's Dealing
2022-05-26 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. It references a press release as Exhibit 99.1 and includes forward-looking statements. The document does not contain detailed financial statements or comprehensive financial analysis, nor does it present a full annual or quarterly report. It is a regulatory filing reporting an event rather than a full financial report or earnings release. The length is 4374 characters, which is relatively short and consistent with a Form 8-K filing. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2022-05-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.